- Home
- AVIR vs ACCO Comparison
AVIR vs ACCO Comparison
Compare AVIR & ACCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVIR | ACCO |
|---|---|---|
| Founded | 2012 | 1893 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Publishing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 318.0M | 373.2M |
| IPO Year | 2020 | 2005 |
Fundamental Metrics
Financial Performance| Metric | AVIR | ACCO |
|---|---|---|
| Price | $4.74 | $4.17 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $6.00 | $6.00 |
| AVG Volume (30 Days) | ★ 580.2K | 527.3K |
| Earning Date | 04-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.21 |
| Revenue | $351,367,000.00 | ★ $1,666,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3.53 |
| P/E Ratio | ★ N/A | $9.74 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.46 | $3.20 |
| 52 Week High | $4.70 | $4.93 |
Technical Indicators
Market Signals| Indicator | AVIR | ACCO |
|---|---|---|
| Relative Strength Index (RSI) | 71.86 | 60.55 |
| Support Level | $4.04 | $4.04 |
| Resistance Level | $4.50 | $4.24 |
| Average True Range (ATR) | 0.24 | 0.11 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 93.23 | 74.70 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ACCO Acco Brands Corporation
ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through two segments: ACCO Brands Americas, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands America segment.